High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma

Lancet

Volumn 355, Issue 9209, 2000, Pages 1071-1072

  Gabarre, Jean ^a   Azar, Nabih ^a   Autran, Brigitte ^a   Katlama, Christine ^a   Leblond, Véronique ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EFAVIRENZ; GRANULOCYTE COLONY STIMULATING FACTOR; INDINAVIR; LAMIVUDINE; NELFINAVIR; SAQUINAVIR; STAVUDINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0034712571     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02041-9     Document Type: Article

References (3)

1. Philip T., Guglielmi C., Hagenbeek A.et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 333:1995;1540-1545.
2. Autran B., Carcelain G., Li T.S.et al. Positive effects of combined antiviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 277:1997;112-116.
3. Gabarre J., Leblond V., Sutton L.et al. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma. Bone Marrow Transplant. 18:1996;1195-1197.